Clinical Trials Logo

Clinical Trial Summary

Background: Atypical atrial flutter (AAF) is an increasingly relevant clinical problem. Despite advancements in mapping and ablation techniques, the general management of these patients remain challenging especially when mapping cannot be performed during ongoing arrhythmia. There are no data whether induction of AAF is a feasible approach in these cases. Methods: The investigators retrospectively analyzed patients who underwent catheter ablation of AAF and compared procedural results between patients with ongoing tachycardia when starting the procedure and patients with induced AAF. For this retrospective study, the investigators analyzed patients undergoing ablation of AAF between April 2018 and January 2021 that were identified from the ablation database at the West German Heart and Vascular Center, Essen. All patients were followed up in the outpatient clinic as part of the clinical standard routine or contacted by telephone to assess the occurrence of clinical recurrence of any arrhythmia. In case the documentation was not performed at the institution, relevant documents and ECGs were requested and reviewed. This single-center cohort study was conducted at the University Hospital Essen, Germany, in accordance with the Declaration of Helsinki and its amendments and was approved by the institutional review board of the University of Essen (number 21-10341-BO). Written informed consent was obtained from all study participants. The primary study endpoint was to evaluate the outcome of patients with induced AAF in comparison to patients with ongoing AAF when starting the procedure. Furthermore, the investigators analyzed the type of recurrence during follow-up as well as the occurrence and results of repeat ablations at the institution. The investigators also evaluated if the recurrent AAF form was the same or de-novo compared to the AAF during previous procedure.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT06323499
Study type Observational
Source University Hospital, Essen
Contact
Status Completed
Phase
Start date April 1, 2018
Completion date October 31, 2021

See also
  Status Clinical Trial Phase
Completed NCT02565238 - BIO.MASTER.BioMonitor 2 Study N/A
Completed NCT02849769 - Magnetic Resonance (MR) Conditional Tachyarrhythmia Therapy Products Post-approval Study
Completed NCT04025710 - Master Study of the BIOMONITOR III and Incision and Insertion Tool (FIT OneStep) N/A
Active, not recruiting NCT05621187 - Post Market Clinical Follow-up Study for the Pamira ICD Lead Family N/A
Not yet recruiting NCT06382207 - Effectiveness of the Eko Digital Stethoscope in Capturing Infant ECGs N/A
Active, not recruiting NCT01526629 - Full Automaticity and Remote Follow-up N/A
Completed NCT03850327 - BIO|CONCEPT.BIOMONITOR III N/A
Recruiting NCT04905199 - Temporary Transvenous Pacemaker Placement by Intracavitary Electrocardiogram Monitoring
Completed NCT03408951 - Surface ECG Signal Recording for the Implantable Subcutaneous String Defibrillator (ISSD) Detection Algorithm Performance Assessment
Not yet recruiting NCT06327425 - MCG for Localization of Tachyarrhythmia's Origin N/A
Recruiting NCT04863664 - Lead EvaluAtion for Defibrillation and Reliability (LEADR) / Lead Evaluation for Defibrillation and Reliability in Left Bundle Branch Area Pacing (LEADR LBBAP) N/A
Not yet recruiting NCT05750108 - Transcutaneous Vagal Nerve Stimulation to Prevent Tachyarrhythmias in Patients Early Following Myocardial Infarction N/A
Completed NCT02774616 - BIO|MASTER.Ilivia Family / Plexa N/A
Completed NCT00231426 - ASSURE Study - Arrhythmia Single Shock DFT Versus ULV: Risk Reduction Evaluation With ICD Implantations Phase 4
Completed NCT02181686 - Iperia/Sentus QP Study N/A
Terminated NCT03451227 - Dexmedetomidine and Fentanyl Versus Midazolam and Remifentanil for Sedation in Patients Undergoing Ablation Procedures N/A
Completed NCT02933619 - ProMRI ICD/CRT-D Post Approval Study
Completed NCT00324662 - Study to Verify Proper Detection of Supraventricular Tachyarrhythmia With Single-Lead Dual-Chamber Implantable Cardioverter-Defibrillators (ADRIA) Phase 4
Completed NCT00170274 - APART: Prevention and Automatic Therapy of Atrial Arrhythmias in Patients With Paroxysmal Supraventricular Tachycardias N/A
Completed NCT03891329 - Master Study of the Acticor/Rivacor ICDs/CRT-Ds and the Plexa ProMRI S DX Lead N/A